# Comparison of Demographic and Clinical Characteristics of Severe Covid-19 Patients with and without Chest Pain

## Authors

- Edip Gonullu ([ORCID](https://orcid.org/0000-0002-4461-4798)) — Bakırçay University Çiğli Training and Research Hospital Department of Anesthesiology and Reanimation, İzmir, Turkey
- Eyup Kebapci ([ORCID](https://orcid.org/0000-0001-8900-2325)) — Bakırçay University Çiğli Training and Research Hospital General Surgery, İzmir, Turkey
- ilhan Bahar ([ORCID](https://orcid.org/0000-0003-3928-7486)) — Bakırçay University Çiğli Training and Research Hospital Department of Anesthesiology and Reanimation, İzmir, Turkey
- Mustafa Berktas ([ORCID](https://orcid.org/0000-0002-4413-0435)) — Bakırçay University Department of Microbiology, İzmir, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 7, Issue 3 (2021), pages 188–192
- **Article type:** Original Article
- **Published online:** 2021-09-26
- **DOI:** [10.5455/umj.20210624084330](https://doi.org/10.5455/umj.20210624084330)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=90340
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/90340.pdf

## Abstract

Introduction: We wanted to evaluate the comparison of clinical and demographic structures of patients admitted to the intensive care unit according to whether they have chest pain or not. Materials and Methods: Clinical records of 134 patients who were hospitalized in the tertiary ICUs of Our Hospital due to COVID-19 between October 1 and November 30, 2020 were reviewed retrospectively. Results: Mortality occurred in 56.7% of the patients. All of these patients were aged over 65 years and hypertension was the most common comorbidity. Mean length of ICU stay was 8 (range, 2-49) days. Eighty-two (61.2%) patients were oxygenated with noninvasive, high-flow nasal oxygen and facemask oxygenation. The remaining 52 (38.8%) patients were ventilated invasively. All patients received antibiotic treatment and 47.8% of them received antiviral (favipiravir) treatment. Conclusion: Mortality occurred in 56.7% of the patients admitted to ICU with the complaint of chest pain. Further studies are needed to substantiate our findings.

## Keywords

Covid-19; Mortality; Chest pain

## How to cite

Gonullu E, Kebapci E, Bahar I, Berktas M. Comparison of Demographic and Clinical Characteristics of Severe Covid-19 Patients with and without Chest Pain. Ulutas Med J. 2021;7(3):188-192. doi:10.5455/umj.20210624084330

## References

1. Damme WV, Dahake R, Delamou A, Ingelbeen B, Wouters E, Vanham G, et al. The COVID-19 pandemic: diverse contexts; different epidemics—how and why? BMJ Global Health.2020; 5(7):e003098
2. Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17):1723
3. Weng LM, Su X, Wang XQ. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. J Pain Res. 2021;14:147-159 192 77 Severe Covid-19 Gonullu et al. https://doi.org/10.2147/jpr.s269206
4. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics - 2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56– 528 https://doi.org/10.1161/cir.0000000000000746
5. Ramakrishnan S, Jabir A, Jayagopal PB, Mohanan PP, Nair VK, Das MK, et al. Pattern of acute MI admissions in India during COVID-19 era: A Cardiological Society of India study Rationale and design. Indian Heart J. 2020 Nov-Dec;72(6):541-546 https://doi.org/10.1016/j.ihj.2020.09.004
6. Hee Kong Fong, Sandeep Singh, Jilmil S. Raina, Vikram B. Itare, Violeta Spasova, Rupak Desai. Alarmingly Increased Public Interest in “Chest Pain” During the COVID-19 Pandemic: Insights From Google Trends Analysis. Cureus 13(4):e14292 https://doi.org/10.7759/cureus.14292
7. Khan S, Rasool ST, Ahmed SI. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us? Curr Probl Cardiol. 2021;100842. doi:10.1016/j.cpcardiol.2021.100842
8. Cannata F, Bombace S, Stefanini GG. Marcadores cardiacos en pacientes con COVID-19: un instrumento práctico en tiempos difíciles [Cardiac biomarkers in patients with COVID - 19: pragmatic tools in hard times]. Rev Esp Cardiol. 2021 Jul;74(7):566-568 https://doi.org/10.1016/j.recesp.2021.01.010
9. Mahajan K, Chand Negi P, Ganju N, Asotra S. Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):929-931 https://doi.org/10.1016/j.dsx.2020.06.027
10. Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E. Acute respiratory distress syndrome. Jama. 2012;307(23):2526–33 https://doi.org/10.1001/jama.2012.5669
11. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708-1720 https://doi.org/10.1056/nejmoa2002032
12. Yang BY, Barnard LM, Emert JM, Drucker C, Schwarcz L, Counts CR, et al. Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington. JAMA Netw Open. 2020;3(7):e2014549 https://doi.org/10.1001/jamanetworkopen.2020.14549
13. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China hypertension survey, 2012 –2015. Circulation. 2018;137(22):2344 –56 https://doi.org/10.1161/circulationaha.117.032380
14. Tocci G, Nati G, Cricelli C, Parretti D, Lapi F, Ferrucci A, et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. Journal of Human Hypertension. 2017;31(4):258–62 https://doi.org/10.1038/jhh.2016.71
15. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JJAMA. 2020;323(20):2052-2059 https://doi.org/10.1001/jama.2020.6775
16. Kulkarni S, Jenner BL, Wilkinson I. COVID -19 and hypertension. J Renin Angiotensin Aldosterone Syst. 2020;21(2): 12-24 https://doi.org/10.1177/1470320320927851
17. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020;96:131-135 https://doi.org/10.1016/j.ijid.2020.04.086
18. Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant H a, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a ity covid-19 center experience. Erciyes Med J 2020;42(4):436-440
19. Zou X, Li S, Fang M, Hu M, Bian Y, Ling J, et al. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019. Crit Care Med. 2020;48(8):e657–65 https://doi.org/10.1097/ccm.0000000000004411